Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory.
Health-Care Horse Trading Before Vote
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Democratic leaders are putting heavy pressure on about eight to 10 of key party members group who opposed the health-care bill when the House voted last fall. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 20, 2010 Category: Pharmaceuticals Tags: PAID Source Type: news
Health Bill Has Democrats Hunting for VotesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Democratic leaders are putting heavy pressure on about eight to 10 of key party members group who opposed the health-care bill when the House voted last fall. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 20, 2010 Category: Pharmaceuticals Tags: PAID Source Type: news
Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold TechnologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott (NYSE: ABT) announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. Patients treated with Abbott's bioresorbable vascular scaffold (BVS), under clinical investigation in Europe, demonstrated no cases of blood clots (thrombosis), no need for repeat procedures (Source: World Pharma News)
Source: World Pharma News - March 20, 2010 Category: Pharmaceuticals Source Type: news
FDA: Not Enough Data on Knee DeviceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA said ReGen Biologics hasn't provided adequate data to show that its knee device is safe. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 19, 2010 Category: Pharmaceuticals Tags: PAID Source Type: news
Health-Bill Horse TradingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Obama said Congress is in position to end a century-long struggle over health care by passing his sweeping overhaul, as Democrats made a final sprint toward a weekend vote. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 19, 2010 Category: Pharmaceuticals Tags: PAID Source Type: news
Medtronic Receives FDA Panel's Unanimous Recommendation for Approval of Revo MRI SureScan Pacing SystemEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Positive Step Toward the First Pacemaker System Approval in the United States for Use in the MRI Environment
MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE:MDT ) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System De... Devices, CardiologyMedtronic, Revo MRI, SureScan, pacemaker (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2010 Category: Pharmaceuticals Source Type: news
MRI-Compatible Pacemaker Wins BackingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An advisory panel recommended that the FDA approve a Medtronic pacemaker designed to allow patients to undergo an MRI scan. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 19, 2010 Category: Pharmaceuticals Tags: PAID Source Type: news
FDA Panel Supports Medtronic PacemakerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An FDA panel recommended the agency approve a Medtronic pacemaker designed to allow patients to undergo an MRI scan. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 19, 2010 Category: Pharmaceuticals Tags: PAID Source Type: news
Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCIEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Results suggest increased need for quantifying patient
response to clopidogrel through point-of-care testing
SAN DIEGO, March 15 /PRNewswire/ -- Accumetrics, Inc., a
privately-held developer and marketer of the VerifyNow® System,
the first rapid... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 19, 2010 Category: Pharmaceuticals Source Type: clinical trials
New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet TherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
More than one out of four patients in analysis had variant in
ABCB1 gene
PARSIPPANY, N.J. and INDIANAPOLIS, March 15
/PRNewswire-FirstCall/ -- A new analysis of the TRITON-TIMI 38
study evaluated response rates in patients with a common... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 19, 2010 Category: Pharmaceuticals Source Type: clinical trials
Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals' Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TOKYO, March 19 (HSMN NewsFeed) -- Astellas Pharma Inc. (TSE:4503.to ) today notified OSI Pharmaceuticals Inc. (Nasdaq:OSIP ) that John D. Gilly, Ph.D. and Margaret T. Monaco will replace Jack Kaye and Heidi L. Steiger on the slate of directors Astellas... Biopharmaceuticals, Mergers & Acquisitions, PersonnelAstellas Pharma, OSI Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2010 Category: Pharmaceuticals Source Type: news
FDA Warns About Increased Risk of Muscle Injury with ZocorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Highest approved dose of cholesterol-lowering medication
could cause harm to muscles
SILVER SPRING, Md., March 19 /PRNewswire-USNewswire/ -- The U.S.
Food and Drug Administration today warned patients and healthcare
providers about the potential for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2010 Category: Pharmaceuticals Source Type: news
Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood CancersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CAMBRIDGE, England, March 19, 2010 (HSMN NewsFeed) -- Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that marketing authorisatio... Biopharmaceuticals, Oncology, RegulatoryMundipharma, Levact, bendamustine, non-Hodgkin's lymphoma, leukemia, myeloma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2010 Category: Pharmaceuticals Source Type: news
CNS Response Announces Thompson Board ResignationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ALISO VIEJO, CA--(HSMN NewsFeed) - CNS Response, Inc. (OTC.BB:CNSO ) has announced that Governor Tommy Thompson has resigned from its Board of Directors, and has agreed to become Chairman of its Advisory Board.
Thompson said that the resignation was fo... Devices, Neurology, Personalized Medicine, PersonnelCNS Response (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2010 Category: Pharmaceuticals Source Type: news
Osmetech to try again for Nasdaq listingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The UK healthcare diagnostics group is seeking to raise $40m through an initial public offer in the US (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 19, 2010 Category: Pharmaceuticals Source Type: news
Obama Touts Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Obama said Congress is in position to end a century-long struggle over health care by passing his sweeping overhaul, as Democrats made a final sprint toward a weekend vote. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 19, 2010 Category: Pharmaceuticals Tags: PAID Source Type: news
Bringing Science to the PlantEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FDA's revised process validation guidance emphasizes risk analysis and statistics. Will it set the stage for continuous improvement? (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - March 19, 2010 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
Patent Application Approval Granted to Eastar Chemical for Novel Prostaglandin TechnologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Eastar Chemical Corporation, a US-based producer of fine and specialty chemicals with manufacturing plants in China and a unique on time, on-spec guarantee, recently celebrated a new milestone in its 25+ year history. With the filing of a key patent application covering a novel and more efficient route to the glaucoma drug Latanoprost and other prostaglandin intermediates, Eastar Chemical has firmly established itself as a strong player in the prostaglandine field and is showing its commitment to grow as an advanced technology company. (PRWeb Mar 18, 2010)
Read the full story at http://www.prweb.com/releases/2010/03/pr...
Source: PRWeb: Medical Pharmaceuticals - March 19, 2010 Category: Pharmaceuticals Source Type: news
BioDiscovery Releases ImaGene 9.0 for Array Image Quantification and VisualizationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BioDiscovery Inc., the leading developer of integrated software solutions for high-throughput technologies announced today the release of ImaGene 9.0 for microarray image analysis. The new features include improved memory performance for the latest high density arrays, streamlined processing pipeline focused on image quantification and intensity extraction, and new modular design with options to add modules for analysis of gene/miRNA expression or CGH data. (PRWeb Mar 18, 2010)
Read the full story at http://www.prweb.com/releases/2010/03/prweb3739684.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2010 Category: Pharmaceuticals Source Type: news
Schwarzenegger Opposes Efforts to Regulate Nutrition and Dietary Supplements (a PMG Report)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Governor tells Bodybuilding & Fitness Community He's Encouraged by Latest Developments Surrounding Senator McCain's Dietary Supplement Act (a PMG Report) (PRWeb Mar 18, 2010)
Read the full story at http://www.prweb.com/releases/schwarzenegger/2010Columbus/prweb3744634.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2010 Category: Pharmaceuticals Source Type: news
Clone Systems, Inc. Debuts Cloud-Based Virtual Data Center SolutionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Clone Systems, Inc. has introduced Clone Guard® CG-PDC, a virtual private datacenter that provides the reliability of dedicated servers coupled with virtually unlimited processing power, high availability and scalability. (PRWeb Mar 18, 2010)
Read the full story at http://www.prweb.com/releases/2010/03/prweb3744384.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2010 Category: Pharmaceuticals Source Type: news
Promega Maxwell® 16 IVD System CE Marked to the European Union IVD Directive Delivers Combined Solution for Infectious DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Promega Maxwell® 16 IVD System is CE marked in accordance with the requirements of Directive 98/79/EC on in vitro diagnostic medical devices. (PRWeb Mar 18, 2010)
Read the full story at http://www.prweb.com/releases/2010/03/prweb3742794.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2010 Category: Pharmaceuticals Source Type: news
ClinAudits Joins Bioanalytical Quality Standards Initiative (BQSI) Expert Working GroupEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ClinAudits, LLC, an independent, 3rd party provider of GXP compliance, clinical trial auditing, and quality remediation solutions for the pharmaceutical, medical device, biotechnology, and tissue engineering industries, announced today that it has joined the Bioanalytical Quality Standard Initiative (BQSI) Expert Working Group. (PRWeb Mar 18, 2010)
Read the full story at http://www.prweb.com/releases/2010/03/prweb3742234.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2010 Category: Pharmaceuticals Source Type: news
New Book Reviews Core Competencies for Pharmacy LeadersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pharmacy Management, Leadership, Marketing & Finance provides pharmacy students and practicing pharmacists with valuable information on topics such as operations management, economic analysis, reimbursement and marketing. This book also features sections on communication, conflict management, professionalism, and human resource strategies – vital competencies for pharmacy leaders and managers. (PRWeb Mar 18, 2010)
Read the full story at http://www.prweb.com/releases/Jones-and-Bartlett/Pharmacy_Management/prweb3742224.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2010 Category: Pharmaceuticals Source Type: news
SCDM to Participate in DIA/FDA meetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Society for Clinical Data Management will provide clinical data management resources and information at the DIA/FDA CDER/CBER Computational Science Annual Meeting, March 22-23 in North Bethesda, Md. (PRWeb Mar 19, 2010)
Read the full story at http://www.prweb.com/releases/2010/03/prweb3745594.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2010 Category: Pharmaceuticals Source Type: news
Stemedica Files IND Application with FDA for Treatment of Stroke with Adult Allogeneic Mesenchymal Stem CellsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke. (PRWeb Mar 19, 2010)
Read the full story at http://www.prweb.com/releases/Stemedica/stem_cells/prweb3751904.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 19, 2010 Category: Pharmaceuticals Source Type: news
BBVA Compass names new Denver presidentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
John Krusoe has been named the new Denver president for BBVA Compass, the bank announced on Friday. (BBVA) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
MicroStrategy added to SP SmallCap 600Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Vienna-based MicroStrategy Inc. has seen its stock more than double in the last year, and that boost in market value will land it on the S&P SmallCap 600 Index. (MSTR) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
Regulators: Few signs that banking is recoveringEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
There are few signs that the banking economy is getting better, bank regulators said at a national banking conference in Orlando Thursday. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
FDA Update: March 22, 2010Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - March 19, 2010 Category: Pharmaceuticals Source Type: news
PNC Bank investigating debit card security breachEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PNC Financial Services Group Inc. is investigating a possible security breach involving some debit cards issued by the former National City Corp., which it acquired in December 2008. (PNC) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
Community banks advised to buy weak rivalsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Attorneys encouraged community bankers yesterday to acquire failed or troubled banks while pricing is low. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
Reply to "The Afterthought Questions That Snarl Up Your Schedule"Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The authors advise listening to patients' last-minute 'afterthought' questions, because they may reveal important problems. Medscape Business of Medicine (Source: Medscape Business of Medicine Headlines)
Source: Medscape Business of Medicine Headlines - March 19, 2010 Category: Pharmaceuticals Tags: Business of Medicine Source Type: info
Charter amends $8.2B credit facilityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Charter Communications Inc. said this week that it received the required votes from lenders to amend its existing $8.2 billion senior secured credit facilities. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
Venture capitalist to offer advice at NussbaumEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Jason Caplain of Southern Capitol Ventures will meet with Triad business owners and hear their business pitches at the Nussbaum Center for Entrepreneurship on April 16. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
Park Bank promotes Werner to presidentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Park Bank of Milwaukee said that David Werner has been appointed president of the bank, while chairman and chief executive officer P. Michael Mahoney, who previously held the title, will continue to serve as chairman and CEO. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
First Mariner shareholders OK stock saleEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
First Mariner Bancorp shareholders on Friday approved the sale of up to $2.6 million in stock to CEO Edwin F. Hale Sr. and other company executives, a key part of the company’s plans to pay down debt and boost capital levels at its First Mariner Bank subsidiary. (FMAR) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
Lilly Discloses Full List Of Drugs In Conn. TheftEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (March 18, 2010)
INDIANAPOLIS -- Drug maker Eli Lilly and Co. said that thieves
who broke into one of its warehouses over the weekend made off with
drugs including the cancer treatments Alimta and Gemzar, and the
blood thinner... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2010 Category: Pharmaceuticals Source Type: news
Theravance Falls On Relovair Comments, Stock OfferEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (March 18, 2010)
NEW YORK -- Shares of Theravance Inc. slid Thursday after the
drug developer announced a stock offering and said it is not sure
what regulators want to see in late-stage clinical trials of its
asthma drug... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2010 Category: Pharmaceuticals Source Type: news
Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New PostsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WASHINGTON, March 18 /PRNewswire-USNewswire/ -- Jeffrey B.
Kindler, Chairman and Chief Executive Officer, Pfizer, was elected
board chairman of the Pharmaceutical Research and Manufacturers of
America (PhRMA) today at the trade association's annual... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2010 Category: Pharmaceuticals Source Type: news
Welsh to market foreclosed Brooklyn Park siteEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Welsh Cos. has been hired to market 610 Crossings in Brooklyn Park, a foreclosed 58-acre site that’s owned by TCF Financial Corp. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
Brown & Brown buys New Jersey firms Excel and SpiritEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Brown & Brown Inc. acquired substantially all of the assets of Excel Underwriters Alliance Inc. and Spirit Underwriters Inc. (BRO) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
Scientists With Ties To Industry More Likely To Write Nice things about drugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Canadian Press DataFile (March 18, 2010)
TORONTO -- Medical authors with ties to diabetes drug makers
were more likely to publish favourable articles on a controversial
diabetes medication than authors who had no such ties, a new... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2010 Category: Pharmaceuticals Source Type: news
Pfizer Scientists Collaborating In New TB InitiativeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
[The Day,
New London, Conn.]
From Day, The (New London, CT) (March 19, 2010)
Mar. 18--Pfizer Inc. scientists in Groton are joining a
worldwide collaboration to find a new drug regimen to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2010 Category: Pharmaceuticals Source Type: news
Astellas Meets Antitrust Mark In OSI AttemptEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (March 19, 2010)
NEW YORK, March 19, 2010 -- Japanese drug maker Astellas
Pharma Inc. said Friday a federal antitrust waiting period expired
in regard to its $3.5 billion takeover bid for OSI Pharmaceuticals
Inc.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2010 Category: Pharmaceuticals Source Type: news
PNC probing Cincinnati-area debit card breachEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PNC Financial Services Group is investigating a possible security breach involving some debit cards issued by the former National City Corp., which it acquired in December 2008. (PNC) (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2010 Category: Pharmaceuticals Source Type: journals
Bovie Medical Corporation Announces Clearance to Market Its BOSS Soft Tissue Coagulation DeviceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MELVILLE, N.Y.--(HSMN NewsFeed)--Bovie Medical Corporation (the Company) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company received clearance from the Food and Drug Administration (FDA) to marke... Devices, Surgery, FDABovie Medical, bipolar sintered steel, soft tissue coagulator, electrosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2010 Category: Pharmaceuticals Source Type: news
OSI Pharmaceuticals Announces That Tarceva(R) Received a Positive Opinion from Health Authorities in the European Union for First-Line Maintenance Use in Advanced Non-Small Cell Lung CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MELVILLE, N.Y.--(HSMN NewsFeed)--OSI Pharmaceuticals, Inc. (Nasdaq: OSIP ) announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use (CHMP) has issued a... Biopharmaceuticals, Oncology, RegulatoryOSI Pharmaceuticals, Roche Group, Tarceva, erlotinib, NSCLC, SATURN trial (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2010 Category: Pharmaceuticals Source Type: news
Stemedica Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem CellsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO, March 19 (HSMN NewsFeed) -- Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administrati... Regenerative Medicine, NeurologyStemedica Cell Technologies, stroke, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2010 Category: Pharmaceuticals Source Type: news
CryoLife Comments on Status of Medafor Distribution AgreementEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ATLANTA, March 19 (HSMN NewsFeed) --- CryoLife, Inc. (NYSE:CRY ), an implantable biological medical device and cardiovascular tissue processing company, today responded to Medafor's allegation that it has repudiated the Exclusive Distribution Agreement (... Devices, Surgery, DistributionCryoLife, Medafor, HemoStase (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2010 Category: Pharmaceuticals Source Type: news
